Many CDMOs are expanding their breadth of capabilities and entering new geographic markets through the acquisition of other service providers.
Evolution in the life sciences industry is driving the need for new manufacturing paradigms based on advanced technologies.
Supply Chain Logistics Providers must be experienced with all relevant customs regulations and the specialized requirements for shipping sensitive materials.
Now stronger than ever, Marken needed a bold visual direction to illustrate its expanding breadth of services and ongoing commitment to personalized medicine.
Nice Insight is in conversation with Dago Caceres, Marketing Director, and Gary Lord, Global Strategic Marketing Director at The Dow Chemical Company
To meet global markets head-on, Bushu and Spera have built a capable proactive organization, that is well positioned in Japan to serve the region.
Transient transfection for vector production offers significant flexibility for cell and gene therapy development.
The Russian market presents new growth opportunities for pharmaceutical companies with manufacturing capabilities within the country.
The pharmaceutical industry, in conjunction with FDA, has focused on identifying approaches for the development of abuse-deterrent opioid formulations
As OSD formulations have grown more sophisticated, technologies to match these advances have been developed for the manufacture of these novel delivery systems.
Pharma’s Almanac has integrated with Nice Insight.
A once-in-a-lifetime journey from Boston to San Diego inspires and garners a deeper understanding of the people who have fueled it all
Like the pharmaceutical industry, relationships between pharmaceutical engineering/design firms and equipment suppliers are constantly in flux.
The global CRO market is expanding and increasingly borderless.
A well-thought-out and structured partnership can bring a sponsor organization both strength and agility.
Experts weigh in on our Roundtable question.